CD&R, McKesson to Acquire Option Care Health for $5.8B
CD&R and McKesson are acquiring Option Care Health, an at-home infusion therapy provider, for approximately $5.8 billion, including debt. CD&R will hold a majority interest of about 51%.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results.
CD&R and McKesson are acquiring Option Care Health, an at-home infusion therapy provider, for approximately $5.8 billion, including debt. CD&R will hold a majority interest of about 51%.
Option Care Health agreed to be acquired by CD&R and McKesson for $32.05 per share, valuing the company at about $5.8B enterprise value, with closing expected in H1 2027 pending approvals.